Is a liver function test the same as the hepatitis B surface antigen (HBsAg) and antibody (HBsAb) test?
Generally speaking, liver function tests and the hepatitis B surface antigen test (commonly known as the "two pairs and a half" test for hepatitis B) are not the same. These two tests serve different purposes and have distinct clinical significance; the choice between them depends on specific needs. Detailed explanation is as follows:

Liver function tests primarily assess the functional status of the liver. By measuring indicators such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, and albumin, these tests help determine whether the liver has damage or inflammation, and whether its synthetic, metabolic, and detoxification functions are normal. In other words, they focus on the liver's current working condition. In contrast, the hepatitis B "two pairs and a half" test specifically detects hepatitis B virus (HBV) infection. It includes five indicators: hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), hepatitis B e antigen (HBeAg), hepatitis B e antibody (HBeAb), and hepatitis B core antibody (HBcAb). The purpose of this test is to determine whether a person has been infected with HBV, assess viral replication status, and identify whether protective antibodies are present. The emphasis is on identifying conditions related to HBV infection.
When undergoing testing, if you want to understand the functional status of the liver, a liver function test is appropriate. If you need to determine whether you have contracted HBV or wish to evaluate the effectiveness of hepatitis B vaccination, the "two pairs and a half" test should be performed. For individuals at risk of HBV infection or experiencing related symptoms, both tests may be necessary to obtain a comprehensive understanding of their condition. If test results are abnormal, timely consultation with a physician is recommended, followed by further management according to professional guidance.